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With the increase of life span, nonpathological age-related memory decline is affecting an increasing number of people. 
However, there is evidence that age-associated memory impairment only suspends, rather than irreversibly extinguishes, 
the intrinsic capacity of the aging nervous system for plasticity (1). Here, using a molluscan model system, we show 
that the age-related decline in memory performance can be reversed by administration of the pituitary adenylate cyclase 
activating polypeptide (PACAP). Our earlier findings showed that a homolog of the vertebrate PACAP38 and its receptors 
exist in the pond snail (Lymnaea stagnalis) brain (2), and it is both necessary and instructive for memory formation after 
reward conditioning in young animals (3). Here we show that exogenous PACAP38 boosts memory formation in aged 
Lymnaea, where endogenous PACAP38 levels are low in the brain. Treatment with insulin-like growth factor-1, which in 
vertebrates was shown to transactivate PACAP type I (PAC1) receptors (4) also boosts memory formation in aged pond 
snails. Due to the evolutionarily conserved nature of these polypeptides and their established role in memory and synaptic 
plasticity, there is a very high probability that they could also act as “memory rejuvenating” agents in humans.
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IT is well known that aging affects memory, but only recently has a likely major molecular cause of age-
related memory loss been discovered. In a gene expression 
study in the human dentate gyrus, 17 genes were identified 
that showed age-related changes (5). The most significant 
change was an age-related decline in RbAp48, a histone-
binding protein that modifies histone acetylation. Inhibition 
of RbAp48 in young mice caused hippocampus-dependent 
memory deficits similar to those associated with aging. On 
the other hand, upregulation of RbAp48 in the dentate gyrus 
of aged wild-type mice ameliorated age-related hippocam-
pus-based memory loss (5). RbAp48 is known to interact 
with a complex of CREB binding protein (CBP, a histone 
acetyl transferase) and phosphorylated CREB1 (pCREB1) 
(6) and thus it was hypothesized that enhancement of the 
PKA-CREB1-CBP pathway and the RbAp48 protein could 
be a target for therapeutic interventions targeting age-
related memory loss (5).
The PKA-CREB1-CBP pathway can be enhanced by 
activating adenylate cyclase, for example, by the applica-
tion of pituitary adenylate cyclase activating polypeptide 
(PACAP). Since its discovery in 1989 as a hypothalamic-
releasing factor, PACAP has been described to have wide-
spread distribution including expression in the pituitary, 
gonads, placenta, intestinal tract, adrenal gland, and central 
and peripheral nervous systems (7). PACAP38 has been 
found to affect both synaptic plasticity and memory pro-
cesses in a number of previous studies in vertebrates (8–13) 
and in invertebrates as well (3). It was shown that PACAP38 
facilitates memory retrieval processes in the extinction 
of the active avoidance reflex in rats (13) and acts as an 
enhancer of mammalian mnemonic processes even at very 
low dosages (12). PACAP38 acts through specific PAC1, 
VPAC1 and VPAC2 receptors, but PAC1 has the largest 
affinity to the polypeptide (14).
The bioactive forms of PACAP and its receptors have 
been remarkably well conserved during evolution (14). 
There is little difference (only three or four amino acids) 
between the amino acid sequences of PACAP38 in verte-
brates and invertebrates (15). This close relatedness pro-
vides a good theoretical base to study the role of PACAP38 
in mechanisms of memory formation in simpler neuronal 
systems. It has already been described that PACAP38 and 
its receptors are present in the pond snail Lymnaea stag-
nalis (2), a well-established invertebrate model organism 
to study evolutionary conserved molecular mechanisms of 
associative learning and memory (16,17). There is also evi-
dence that this polypeptide is both necessary and instructive 
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for long-term memory (LTM) formation after food-reward 
classical conditioning in young Lymnaea (3).
A number of previous studies have demonstrated age-
related impairment of associative memory in Lymnaea 
(18,19). Other studies characterized age-related changes 
in key identified neurons of the feeding and respiratory 
network, the circuits used for classical conditioning and 
operant conditioning, respectively (1,20–23). Two of these 
studies (1,22) identified specific electrical changes in iden-
tified neurons as the likely underlying cause of age-related 
memory loss.
A detailed knowledge of the conserved molecular cas-
cades (eg, cAMP-PKA-CREB1-CBP) underlying behavio-
ral LTM in Lymnaea (17), together with the already existing 
information on the cellular and molecular mechanisms of 
age-related memory loss in this species (1,22) provided us 
with an ideal model system in which to test the hypothesis 
that PACAP could reverse memory loss in older age. Here 
we used a combination of molecular and behavioral meth-
ods to measure endogenous PACAP expression levels in 
the “learning ganglia” of young and aged snails and to test 
the effect of PACAP on memory in older animals. IGF-I 
supplementation in rodents has been reported to amelio-
rate hippocampal-dependent cognitive deficits associated 
with normal aging (24), but its effect on LTMafter classical 
conditioning has not been investigated. Based on the find-
ing that insulin-like growth factor-1 (IGF-1) transactivates 
PACAP type I  (PAC1) receptors and 86% of the down-
stream protein targets are shared between the PACAP- and 
IGF-1-activated pathways (4), we also tested the effect of 
IGF-1 on memory formation in aged animals.
Materials and Methods
Experimental Animals
Pond snails (L. stagnalis) were bred at the University 
of Sussex. Animals of different ages were kept in separate 
large holding tanks filled with Cu2+-free water (18–20°C). 
Snails were kept under 12-hour light–dark cycles and fed 
ad libitum with lettuce and a vegetable-based fish food 
(TETRA Werke). They were food deprived for 2  days 
before the beginning of the experiments.
Although snails survive over a year in our breeding facility, 
two age categories, 3 and 8 months old, were selected based 
on the age categorization by Hermann and coworkers (19), to 
compare learning performance in young and older animals.
training Procedure
A single-trial appetitive classical conditioning protocol 
was used (3,25,26) to train young and older animals (aged 
3 and 8 months, respectively). Before training, the animals 
were left in the experimental dish (14-cm diameter Petri 
dish) for 10 minutes to acclimatize. Then the conditioned 
stimulus (CS), amyl acetate (0.004% final concentration), 
was introduced, followed by the unconditional stimulus, 
sucrose (0.67% final concentration), 15 seconds later. The 
CS and unconditional stimulus pairing lasted for 2 minutes, 
and the animals were rinsed and placed back to their original 
holding tanks. Memory tests were performed 1 hour and 24 
hours after the training. The 1 hour represents intermediate-
term memory (ITM), whereas the 24-hour time point refers 
to LTM in Lymnaea (27). For testing, individual snails were 
taken from their home tanks using a blind procedure and 
placed in Petri dishes. After a 10-minute acclimatization 
period, rasps were counted for 2 minutes (ie, spontaneous 
rasping in the absence of the CS). Five milliliters of the CS 
was then applied to the dish, and rasps were counted for 
further 2 minutes (ie, rasping in the presence of the CS). 
The feeding response to the CS was defined as the number 
of rasps in the presence of CS minus the number of spon-
taneous rasps.
treatment of Animals With a PACAP Receptor 
Antagonist or PACAP38
Experimental animals were injected with 100 μL of 
PACAP38 (1.0 μM final concentration) diluted in saline, 
saline, or antagonist, PACAP6-38 (2.5 μM final concentra-
tion) 60 minutes before training.
treatment of Animals With IGF-1
Aged animals were injected with 100 μL of IGF-1 
(1.3 μM final concentration) diluted in saline or IGF-1 com-
bined with M65, a specific antagonist of PAC1 receptors 
(2 μM final concentration) 60 minutes before training.
Western Blot Assays
Protein sample preparation.—Lymnaea protein samples 
for western blot were prepared from buccal and cerebral 
ganglia dissected from young and aged snails and collected 
on dry ice. Proteins from ganglia were solubilized using 
ice-cold Tris homogenization lysis buffer (20 mM Tris pH 
7.5, 1 mM ethylene diamine tetra-acetic acid, 5 mM dithi-
othreitol, 10% Glycerol, 1% Protease inhibitor, and 1% 
Triton X-100) and incubated for 30 minutes on rocker at 
4°C. Later, samples were centrifuged at 10,000g, and 
resultant supernatants were collected and purified using 
chilled acetone. Precipitated proteins were centrifuged and 
air dried at room temperature before solubilization in Tris 
buffer (125 mM Tris–HCl, pH 6.8).
Sodium dodecyl sulfate–polyacrylamide gel electropho-
resis and immunoassays.—Purified and solubilized pro-
tein samples were reduced by heating in 2× concentrated 
reducing sodium dodecyl sulfate–polyacrylamide gel elec-
trophoresis sample buffer (50 mM Tris pH 6.8, 2% (w/v) 
sodium dodecyl sulfate, 10% glycerol, 0.1 M dithiothreitol, 
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5% β-mercaptoethanol, 0.01% bromophenol blue), and 
equal volumes of proteins were loaded into each lane of 
a polyacrylamide gel, after appropriate protein measure-
ments. The stacking gel was composed of 4% acrylamide, 
and the two gradients of the separating gel were composed 
of 10% and 20% acrylamide, respectively. Prestained color 
markers (CM; BioRad) and a biotinylated protein ladder 
for horse radish peroxidase detection (Cell Signalling) 
were used as molecular mass markers. Separated proteins 
were blotted overnight onto Hybond-P membrane (poly-
vinylidenefluoride, GE Healthcare). The blotted polyvi-
nylidenefluoride membrane was then cut into two sections/
strips (following CM mass marker), and appropriate parts 
of the membranes were then immune assayed with their 
respective antibodies. Membranes for anti-PACAP38 were 
preblocked with 5%–6% bovine serum albumin and 2% 
NRS (Normal Rabbit Serum) in Tris-buffered saline con-
taining 0.15% Tween-20 (Tris-buffered saline/T20), and 
membranes for anti-β-actin were preblocked with 5% milk 
in 0.15% Tris-buffered saline/T20, for 90 minutes, at room 
temperature. Primary antibody incubation performed with 
sheep polyclonal anti-PACAP (1:5,000; Abcam) and mouse 
monoclonal anti-β-actin (1:4,000; Sigma) overnight at 
4°C. Horse radish peroxidase-conjugated rabbit anti-sheep 
immunoglobin G (1:25,000; Abcam) and goat anti-mouse 
immunoglobin G (1:1,000; Cell Signalling) were used 
to detect the bound primary antibodies and were visual-
ized using enhanced chemiluminescence (Immobillon, 
Millipore). Synthetic PACAP38 was used in every experi-
ment as positive control and run alongside protein samples 
from young and aged brains, to identify the appropriate 
Lymnaea PACAP38-like bands. Densitometric analysis was 
performed using ImageJ software from National Institutes 
of Health. Values for the PACAP38-like bands were normal-
ized relative to their corresponding β-actin bands (used as 
internal standard). The analysis was repeated 3 times with 
brain samples obtained from separate batches of animals.
Statistics
In the behavioral experiments, comparisons between 
groups were carried out using either t tests, nonparamet-
ric Mann–Whitney tests, or a one-way analysis of variance, 
followed by a suitable post hoc test. Parametric tests were 
only performed on data showing Gaussian distribution. All 
statistical analyses were carried out using Prism (GraphPad 
Software). An unpaired t test was used to analyze the west-
ern blot results. Differences were considered significant at 
values p < .05.
Results
To test the memory retention in young and older snails, 
a group of 3-month-old (n  =  18) and another group of 
8-month-old snails (n = 17) were trained in the single-trial 
appetitive classical conditioning paradigm. Both groups 
were tested 1 hour and 24 hours after training. At both 
testing times, young animals responded significantly 
higher to the CS than aged ones (Figure 1; Mann–Whitney 
test, 1 hour: p < .0004, 24 hours: p < .03), indicating that 
there is a deficit in the recall of both ITM and LTM in 
older age. This raised the question whether the reduced 
ability to recall memory in older age was due to reduced 
receptor activity.
Our previous work (3) showed that the PACAP receptor 
antagonist PACAP6-38 prevents the formation of LTM in 
young animals. Here we tested whether ITM formation, 1 
hour after training, was also affected. Two groups of young 
animals were injected either with vehicle solution (n = 18) 
or with PACAP6-38 (n = 17). The behavioral tests showed 
that like the 24-hour memory, the 1-hour memory was also 
impaired after treatment with the antagonist (Figure  2; 
Mann–Whitney test, 1 hour: p < .001; 24 hours: p < .014). 
These results showed that reduced PACAP receptor activity 
leads to memory impairment even in young animals both in 
the intermediate and in the long term.
Figure 1. Age-related impairment of both intermediate-term memory (ITM) 
and long-term memory (LTM) in Lymnaea. Time line of experiment is shown 
above the graph. ITM was tested 1 hour, whereas LTM was tested 24 hours, 
after single-trial food-reward classical conditioning. Means ± SEM are shown. 
Asterisks indicate statistical significance.
 at U
niversity of Sussex on July 28, 2014
http://biom
edgerontology.oxfordjournals.org/
D
ow
nloaded from
 
Page 4 of 8 PIRGER Et AL.
The question then arose whether it is indeed the dimin-
ished activity or reduction in the number of PACAP receptors 
or a reduced PACAP level that causes the defect in memory 
recall at older age. We hypothesized that if the receptors 
were affected in older snails, exogenous PACAP could not 
reverse age-related memory loss. To test this hypothesis, 
we injected older snails with synthetic PACAP38 to pro-
vide plenty of surplus agonist for the receptors during the 
acquisition and early consolidation of long-term memory. 
The results of this experiment show (Figure 3) that boost-
ing the availability of PACAP38 during acquisition in older 
animals could reverse the age-related decline in memory. 
The comparison of vehicle-injected older animals (n = 17) 
with PACAP38 injected ones (n = 16) show that synthetic 
PACAP38 significantly improved memory at both 1 hour 
and 24 hours after training (Mann–Whitney test, 1 hour: p 
< .036, 24 hours: p < .039). These results indicated that it 
is the reduced availability of the endogenous PACAP-like 
polypeptide in aged animals, not the decline in receptors, 
that leads to memory impairment. To further investigate this 
possibility, we used western blot techniques to detect differ-
ences in the quantity of the Lymnaea PACAP-like polypep-
tide in older and young animals.
An example of the five western blot gels each contain-
ing the homogenate of 10 snail buccal and cerebral gan-
glia (the “learning ganglia” of Lymnaea (17)) is shown 
in Figure  4A. The band visible in the brain sample from 
young snails is in line with the band of synthetic PACAP38. 
Densitometry measurements (Figure 4) showed that there 
was significantly less PACAP38-like peptide in the samples 
from older snails than in the ones from young animals (two-
tailed unpaired t test, p < .001). This finding confirmed that 
there was an age-related reduction in the expression of the 
Lymnaea homolog of PACAP in the “learning ganglia.”
There is indication that similarly to PACAP, IGF-1 can 
also act as a potent neurotrophic and antiapoptotic factor 
(4). It was believed that IGF-1 exerted its effects via phos-
phorylation cascades initiated by tyrosine kinase. However, 
Figure  3. Exogenous PACAP reverses memory impairment in aged 
Lymnaea. Time line of experiment is shown above the graph. Injection with 
synthetic PACAP38 rescued both ITM and LTM from age-related impairment. 
Means ± SEM are shown. Asterisks indicate statistical significance.
Figure  2. Endogenous pituitary adenylate cyclase activating polypeptide 
(PACAP) is required for both ITM and LTM in young Lymnaea. Time line 
of experiment is shown above the graph. Injection with the PAC1 antagonist 
PACAP6-38 (anti-PACAP) 60 minutes before single-trial food-reward classical 
conditioning caused significant (asterisks) impairment of both ITM and LTM. 
Means ± SEM are shown.
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more recent results suggest that it involves a complex sign-
aling network dependent on the PAC1 G-protein-coupled 
receptor in neurons (4). These findings suggest that IGF-1 
could also induce the molecular cascades activated by 
PACAP through the transactivation of PAC1 receptors. It is 
also known that IGF-1 plays an important role in mamma-
lian aging (28–37). To test the effect of IGF-1 on associa-
tive memory formation in relation to aging, we injected a 
group of aged snails with recombinant human IGF-1 (R&D 
Systems, 291-G1) and another group with IGF-1 combined 
with M65 (PAC1 receptor specific antagonist; Bachem AG, 
Switzerland, H-6736). The memory test at 24 hours after the 
training showed that similarly to synthetic PACAP38, IGF-1 
boosted long-term memory in older animals (Figure  5). 
IGF-1 improved memory even when applied together with 
the PAC1 antagonist (Figure 5), confirming previous find-
ings that IGF-1 transactivates unliganded PAC1 receptors 
resulting in the phosphorylation state of PKA substrates(4).
Discussion
Here we introduce a novel invertebrate model of age-
related learning deficit and how it can be ameliorated by sup-
plementation with the polypeptides PACAP38 and IGF-1.
A large number of neuropeptides have been linked to 
both memory function and disease-related dysfunction in 
mammalian models of learning and memory (38). Although 
it is known that aging leads to a decline in neuropeptide 
expression in the brain (39,40), the role of neuropeptide 
dysregulation in age-associated memory deficits is not well 
understood. Here, using both a loss-of-function and a gain-
of-function approach, we first established a role for a highly 
conserved polypeptide, PACAP, in age-related memory 
decline after reward-based classical conditioning.
Previous work (2,15,41,42) already has indicated that 
PACAP and its most specific receptor (PAC1) exist in the 
molluscs Helix and Lymnaea. Pirger and coworkers (3) 
have also shown that in young Lymnaea application of the 
PACAP receptor antagonist PACAP6-38 around the time of 
acquisition impairs 24-hour memory (LTM). Our present 
results confirmed this previous finding and furthermore 
showed that injecting young (3-month-old) animals with 
the PACAP receptor antagonist prevented not only LTM but 
also ITM at 1 hour after training. It seems therefore that in 
Lymnaea PACAP is required for both translation-dependent 
and transcription-dependent forms of associative memory. 
In the mammalian brain, the thalamus, hypothalamus, hip-
pocampus (dentate gyrus), cerebellum, and olfactory bulb 
are the regions containing the PAC1 receptor in the highest 
density (43). These brain areas are proven to be involved in 
Figure 4. Age-related reduction of endogenous PACAP levels in the “learn-
ing ganglia” of Lymnaea. (A) Western blot bands of synthetic PACAP38 and 
endogenous Lymnaea PACAP at approximately 9 kDa. In both young and aged 
Lymnaea, endogenous actin (~40 kDa) was also assayed in the same samples 
that were used for PACAP detection. The level of endogenous PACAP was 
below detection threshold in the sample from aged snail brains shown here. (B) 
Endogenous PACAP expression is significantly (asterisk) lower in aged versus 
young brain samples. Means ± SEM are shown.
Figure 5. Exogenous insulin-like growth factor-1 reverses memory impair-
ment in aged Lymnaea. Time line of experiment is shown above the graph. 
Similar to PACAP38 (see Figure 3), injection with synthetic insulin-like growth 
factor-1 rescued LTM from age-related impairment. ITM was not tested in 
this experiment. For comparison, the conditioned feeding response in vehicle-
injected young animals in the same experiment at 24 hours after single-trial 
classical conditioning is also shown. Means ± SEM are shown. Asterisks indi-
cate statistical significance.  at U
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learning and memory processes and experiments with gene 
deficient animals (44), and pharmacological interventions 
(45) indicate a critical role for PACAP in these mechanisms. 
However, previous work in mammals concentrated on the 
role of PACAP in learning and memory without studying 
the involvement of PACAP and its receptors in mechanisms 
of ITM and LTM during aging.
Our experiments show that in aged Lymnaea, there is a sig-
nificant deficit of both ITM and LTM after one-trial reward 
conditioning. The deficit in both of these types of memory, 
however, was rescued by the application of the synthetic 
PACAP38 peptide before training. The general memory 
enhancing effect of PACAP has been investigated in mice 
(12,13) using genetic manipulations and receptor blockers, 
but no studies were performed with aging animals. We meas-
ured the quantity of PACAP in the “learning ganglia” of aged 
snails and found that it was significantly lower compared with 
young animals. This finding supports our hypothesis that it 
is the reduced availability of PACAP that leads to reduction 
in memory performance in aged animals. Du and cowork-
ers (46) investigated age-related changes in PACAP using 
similar methods to ours in the gerbil hippocampus at various 
ages. Their results also indicated that the number of PACAP-
immunoreactive cells is lower in the adult stage than in juve-
niles. However, PACAP immunoreactivity in the mossy fiber 
zone and PACAP protein level in the hippocampus were 
highest in the adult stage. This suggests that although there is 
a global downregulation in the level of PACAP, there are spe-
cific regions in the brain where local upregulation can occur. 
However, establishing the functional consequences of these 
local differences would need further investigation.
Recently, Lee and coworkers (47) demonstrated that 
PAC1 receptor immunoreactivity was significantly 
increased in the hypothalamus, thalamus, midbrain, septal 
nuclei, and white matter of aged rat brains, whereas VPAC2 
receptor immunoreactivity was unchanged. These results 
also support the notion that it is the level of the available 
neuropeptide, not the number of receptors, that is responsi-
ble for age-related memory deficits.
Importantly, we also found that IGF-1 had a similar 
memory-boosting effect on aged snails as PACAP38. This 
can be explained by the previous finding that IGF-1 transac-
tivates PAC1 receptors (4) and thus effectively leads to the 
activation of the same downstream molecular cascades that 
are activated by PACAP during memory acquisition.
In a recent study, pharmacological inhibition of phos-
pholipase A
2
 was found to reverse long-term memory 
impairment and underlying neural defects both in aged 
and oxidatively stressed young Lymnaea (1). This previous 
study used multitrial operant conditioning of aerial respira-
tion, and it will be interesting to investigate whether phos-
pholipase A
2
 plays a similar key role in age-related memory 
decline after single-trial classical conditioning. Likewise, it 
will be interesting to find out if PACAP and IGF-1 have 
a similar memory rescuing effect on older snails after 
operant conditioning that we observed here after classical 
conditioning. The Wildering laboratory used the single-trial 
food-reward conditioning paradigm to identify the failure 
of an earlier described type of delayed nonsynaptic neu-
ronal plasticity (48) as an underlying cause of age-related 
memory impairment (22). It will be therefore important 
to investigate if PACAP38 or IGF-1 treatment reverses 
age-related memory impairment by restoring nonsynaptic 
plasticity in key neurons of the feeding network, similar to 
the restorative effect of inhibiting phospholipase A
2
 on key 
neurons of the respiratory network in the case of operant 
conditioning (1).
Research into age-related behavioral and cellular changes, 
including memory impairment and underlying neural defi-
cits, have now firmly established Lymnaea as a highly trac-
table model system for exploring the molecular mechanisms 
of age-associated memory decline. So far phospholipase 
A
2
 (1), PACAP38, and IGF-1 (this study) have emerged as 
prospective targets for the reversal of age-related cognitive 
deficits. These molecules and related biochemical cascades 
have been highly conserved during evolution and thus the 
findings from Lymnaea can inform new studies exploring 
these pathways for their role in cognitive decline in the 
aging human brain and lead to more translationally oriented 
research aimed at developing new therapeutic approaches to 
age-associated memory dysfunction.
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